Author： Lenz Johannes Carl Christoph Rockstroh Jüürgen Kurt
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.20, Iss.4, 2011-04, pp. : 537-548
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Lenz Johannes Carl Christoph Rockstroh Jürgen Kurt
Expert Opinion on Drug Metabolism and Toxicology, Vol. 6, Iss. 9, 2010-09 ,pp. :
Access to resources
Recommend
Raltegravir: an integrase inhibitor for HIV-1
By Evering Teresa H Markowitz Martin
Expert Opinion on Investigational Drugs, Vol. 17, Iss. 3, 2008-03 ,pp. :
Elvitegravir: a once-daily inhibitor of HIV-1 integrase
Expert Opinion on Investigational Drugs, Vol. 21, Iss. 3, 2012-03 ,pp. :
HIV-1 Integrase: A Target for New AIDS Chemotherapeutics
Current Topics in Medicinal Chemistry, Vol. 4, Iss. 9, 2004-05 ,pp. :